#United States #Hattiesburg #Rovia Clinical Research #Hattiesburg Clinic #Dr. Rambod Rouhbakhsh

Rovia Clinical Research Partners with Hattiesburg Clinic

Rovia Clinical Research, a multi-specialty clinical research site network, has announced a strategic partnership with the Hattiesburg Clinic to establish a new clinical research site in Hattiesburg, Mississippi. This collaboration aims to enhance the delivery of clinical trials in the region, which is considered underserved in terms of healthcare research access.

The Hattiesburg Clinic is a prominent healthcare provider, boasting the largest privately-owned multi-specialty health system in Mississippi. With a robust network of over 450 physicians and providers serving approximately 2,000 staff members, the clinic caters to patients across 17 counties. This new site will not only widen Rovia’s operational reach but will also bolster its capabilities in several key therapeutic areas that are critical for advancing clinical research.

Leading this new initiative is Dr. Rambod Rouhbakhsh, a respected physician specializing in family medicine as well as occupational and environmental medicine. Dr. Rouhbakhsh also serves as the program director of the Forrest General Hospital Family Medicine Residency Program. His involvement in this partnership signifies a commitment to improving patient outcomes and advancing the field of research through rigorous clinical trials.

Rovia’s CEO, Patricio Casillas, expressed enthusiasm for the partnership, emphasizing how it aligns with Rovia's mission to provide high-quality clinical research services while expanding their footprint into Mississippi. He stated, “The Hattiesburg Clinic and Dr. Rouhbakhsh are highly respected in the region and nation, and we are thrilled to partner with them to launch this new site in an underserved, major geographic region.”

This new research site aims to facilitate various clinical trials while ensuring patient-centric care. Rovia is known for its exceptional service levels, which include rapid study start-up, achieving enrollment targets, high patient retention, and robust data quality. The company has been a trusted partner for many global pharmaceutical and biotech firms, thanks to its proven track record in delivering fast and reliable clinical research results.

With over 18 years of experience, Rovia operates a mix of free-standing and physician-embedded research sites throughout the United States. Its core research interests encompass multiple therapeutic areas, including endocrinology, obesity, cardiology, gastroenterology, neurology, ophthalmology, and infectious diseases. Through this collaboration with Hattiesburg Clinic, Rovia anticipates an increase in patient recruitment capacity and enhanced quality of care in clinical studies.

In addition to providing efficient trial management, Rovia also prioritizes patient engagement through exceptionally streamlined processes. The company leverages its centralized teams alongside local market knowledge to create high-quality research opportunities. Notably, this partnership illustrates Rovia’s broader commitment to fostering collaboration among diverse healthcare stakeholders while prioritizing access to clinical trials for underserved communities.

As Rovia begins operations at the new site in Hattiesburg, it aims not only to carry out clinical trials but to systematically shape the future landscape of medical research and drug development. By engaging with local healthcare providers like the Hattiesburg Clinic, Rovia is set to make significant contributions to scientific knowledge and improve patient care outcomes in the region. This collaboration exemplifies the importance of integrating clinical research with accessible healthcare, a crucial endeavor in today's medical landscape.

For more information about Rovia Clinical Research and its initiatives, visit their official website.